N Sonino1, M Boscaro, F Fallo, G A Fava. 1. Department of Surgical and Medical Sciences, Division of Endocrinology, University of Padova, Italy.
Abstract
BACKGROUND: In assessing the clinical response to medical and/or surgical treatments in patients with established Cushing's syndrome, the need for an instrument that could measure the magnitude of changes in the most common symptoms was felt. We therefore tested the usefulness of a simple clinical index, the Cushing's syndrome severity index (CSI), based on clinimetric principles. Eight clinical features were selected. Each one was graded on an ordinal 3-point scale (0-2) with specification of anchor points based on severity. The total score ranged from 0 to 16. METHODS: Interrater agreement, construct validity and concurrent validity of the index were evaluated. Fourteen patients with Cushing's syndrome were evaluated independently by 2 endocrinologists before and after successful treatment. The CSI and two global scales of illness severity were administered. Urinary cortisol measurements were also performed. RESULTS: The intraclass correlation coefficient of the CSI was 0.95 before treatment and 0.87 after treatment. The CSI significantly discriminated (p<0.001) the effects of treatment and paralleled the changes in urinary cortisol. There were significant correlations between CSI and global scales of illness severity and change after treatment. CONCLUSION: The results indicate that the CSI is a valid and reliable clinimetric method to evaluate severity in Cushing's syndrome. It may provide a tool for better assessing the complex array of signs and symptoms in this condition. The index is suitable for descriptive studies, outcome investigations and treatment trials. Copyright 2000 S. Karger AG, Basel.
BACKGROUND: In assessing the clinical response to medical and/or surgical treatments in patients with established Cushing's syndrome, the need for an instrument that could measure the magnitude of changes in the most common symptoms was felt. We therefore tested the usefulness of a simple clinical index, the Cushing's syndrome severity index (CSI), based on clinimetric principles. Eight clinical features were selected. Each one was graded on an ordinal 3-point scale (0-2) with specification of anchor points based on severity. The total score ranged from 0 to 16. METHODS: Interrater agreement, construct validity and concurrent validity of the index were evaluated. Fourteen patients with Cushing's syndrome were evaluated independently by 2 endocrinologists before and after successful treatment. The CSI and two global scales of illness severity were administered. Urinary cortisol measurements were also performed. RESULTS: The intraclass correlation coefficient of the CSI was 0.95 before treatment and 0.87 after treatment. The CSI significantly discriminated (p<0.001) the effects of treatment and paralleled the changes in urinary cortisol. There were significant correlations between CSI and global scales of illness severity and change after treatment. CONCLUSION: The results indicate that the CSI is a valid and reliable clinimetric method to evaluate severity in Cushing's syndrome. It may provide a tool for better assessing the complex array of signs and symptoms in this condition. The index is suitable for descriptive studies, outcome investigations and treatment trials. Copyright 2000 S. Karger AG, Basel.
Authors: Steven J A van der Werff; J Nienke Pannekoek; Cornelie D Andela; Onno C Meijer; Mark A van Buchem; Serge A R B Rombouts; Roos C van der Mast; Nienke R Biermasz; Alberto M Pereira; Nic J A van der Wee Journal: Neuropsychopharmacology Date: 2015-02-05 Impact factor: 7.853
Authors: Troels K Bergmann; Nicole M Isbel; Remo Ostini; Katherine A Barraclough; Scott B Campbell; Brett C McWhinney; Warrick J Inder; Anthony Russell; Christine E Staatz Journal: Clin Drug Investig Date: 2015-11 Impact factor: 2.859
Authors: Leonie H A Broersen; Femke M van Haalen; Nienke R Biermasz; Daniel J Lobatto; Marco J T Verstegen; Wouter R van Furth; Olaf M Dekkers; Alberto M Pereira Journal: Orphanet J Rare Dis Date: 2019-03-11 Impact factor: 4.123
Authors: Steven J A van der Werff; Cornelie D Andela; J Nienke Pannekoek; Onno C Meijer; Mark A van Buchem; Serge A R B Rombouts; Roos C van der Mast; Nienke R Biermasz; Alberto M Pereira; Nic J A van der Wee Journal: Neuroimage Clin Date: 2014-02-10 Impact factor: 4.881
Authors: Laurence Katznelson; D Lynn Loriaux; David Feldman; Glenn D Braunstein; David E Schteingart; Coleman Gross Journal: Clin Endocrinol (Oxf) Date: 2013-10-17 Impact factor: 3.478